The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVp Regulatory News (VP.)

Share Price Information for Vp (VP.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 652.50
Bid: 610.00
Ask: 665.00
Change: 0.00 (0.00%)
Spread: 55.00 (9.016%)
Open: 652.50
High: 0.00
Low: 0.00
Prev. Close: 652.50
VP. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

29 Jul 2022 10:13

RNS Number : 2558U
Singer Capital Markets Sec Ltd
29 July 2022
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Singer Capital Markets Securities LTD

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Vp PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

Vp PLC

(d) Date dealing undertaken:

28 July 2022

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

If YES, specify which:

 

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 5P

 

 

Purchase

 

2,124

 

877p

 

877p

 

ORD 5P

 

 

Sale

 

2,124

 

877p

 

877p

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

29 July 2022

Contact name:

Sarah-Rose Perry, Jennifer Bentick

Telephone number:

020 7496 3093

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERUKAKRUOUBURR
Date   Source Headline
8th Jun 20217:00 amRNSFinal Results
27th May 20217:00 amRNSPresentation via Equity Development
24th May 20218:35 amRNSNotice of Final Results
11th May 20214:36 pmRNSPrice Monitoring Extension
30th Apr 20214:41 pmRNSSecond Price Monitoring Extn
30th Apr 20214:36 pmRNSPrice Monitoring Extension
8th Apr 20214:41 pmRNSSecond Price Monitoring Extn
8th Apr 20214:36 pmRNSPrice Monitoring Extension
7th Apr 20217:00 amRNSTrading Update
1st Apr 20217:00 amRNSAppointment of Joint Corporate Broker
3rd Feb 20214:31 pmRNSDirector/PDMR Shareholding
3rd Feb 20214:28 pmRNSDirector/PDMR Shareholding
4th Jan 20214:41 pmRNSSecond Price Monitoring Extn
4th Jan 20214:36 pmRNSPrice Monitoring Extension
23rd Dec 20204:41 pmRNSSecond Price Monitoring Extn
23rd Dec 20204:36 pmRNSPrice Monitoring Extension
17th Dec 20208:09 amRNSStatement re. CMA infringement notice
7th Dec 20207:00 amRNSInterim Results
27th Nov 20207:00 amRNSNotice of Half Year Results
27th Oct 20204:41 pmRNSSecond Price Monitoring Extn
27th Oct 20204:35 pmRNSPrice Monitoring Extension
27th Oct 202010:50 amRNSDirector/PDMR Shareholding
23rd Oct 20204:41 pmRNSSecond Price Monitoring Extn
23rd Oct 20204:36 pmRNSPrice Monitoring Extension
6th Oct 20207:00 amRNSTrading Update
14th Aug 20204:41 pmRNSSecond Price Monitoring Extn
14th Aug 20204:36 pmRNSPrice Monitoring Extension
23rd Jul 202012:10 pmRNSResult of Annual General Meeting
23rd Jul 20207:00 amRNSAGM Statement
29th Jun 202012:07 pmRNSSecond Price Monitoring Extn
29th Jun 202012:02 pmRNSPrice Monitoring Extension
24th Jun 20204:36 pmRNSPrice Monitoring Extension
22nd Jun 20207:00 amRNSAnnual Report, Notice of AGM & Form of Proxy
10th Jun 20207:00 amRNSFinal Results
5th Jun 20204:41 pmRNSSecond Price Monitoring Extn
5th Jun 20204:36 pmRNSPrice Monitoring Extension
3rd Jun 202012:30 pmRNSNotice of Final Results
13th May 20204:41 pmRNSSecond Price Monitoring Extn
13th May 20204:35 pmRNSPrice Monitoring Extension
4th May 20204:41 pmRNSSecond Price Monitoring Extn
4th May 20204:35 pmRNSPrice Monitoring Extension
25th Mar 20204:43 pmRNSSecond Price Monitoring Extn
25th Mar 20204:38 pmRNSPrice Monitoring Extension
25th Mar 20207:00 amRNSTrading and COVID-19 Update
13th Feb 20204:21 pmRNSHolding(s) in Company
17th Dec 201912:08 pmRNSSecond Price Monitoring Extn
17th Dec 201912:02 pmRNSPrice Monitoring Extension
12th Dec 20195:01 pmRNSDirector/PDMR Shareholding
12th Dec 20194:57 pmRNSDirector/PDMR Shareholding
12th Dec 20191:29 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.